These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34845932)

  • 21. Oxidation-specific biomarkers and risk of peripheral artery disease.
    Bertoia ML; Pai JK; Lee JH; Taleb A; Joosten MM; Mittleman MA; Yang X; Witztum JL; Rimm EB; Tsimikas S; Mukamal KJ
    J Am Coll Cardiol; 2013 May; 61(21):2169-79. PubMed ID: 23541965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study.
    Gao JW; Hao QY; Gao M; Zhang K; Li XZ; Wang JF; Vuitton DA; Zhang SL; Liu PM
    Cardiovasc Diabetol; 2021 Jun; 20(1):126. PubMed ID: 34167539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboembolic events in atrial fibrillation: Different level of risk and pattern between peripheral artery disease and coronary artery disease.
    Lin YS; Wu VC; Chen YL; Liu CH; Chen HC; Lee WC; Yang TY; Aboyans V; Chen MC
    Arch Cardiovasc Dis; 2021 Mar; 114(3):176-186. PubMed ID: 33518472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease.
    Hayek SS; MacNamara J; Tahhan AS; Awad M; Yadalam A; Ko YA; Healy S; Hesaroieh I; Ahmed H; Gray B; Sher SS; Ghasemzadeh N; Patel R; Kim J; Waller EK; Quyyumi AA
    Circ Res; 2016 Aug; 119(4):564-71. PubMed ID: 27267067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
    Emery C; Torreton E; Briere JB; Evers T; Fagnani F
    J Med Econ; 2020 May; 23(5):513-520. PubMed ID: 31928390
    [No Abstract]   [Full Text] [Related]  

  • 27. Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks.
    Lee J; Gilliland T; Koyama S; Nakao T; Dron J; Lannery K; Wong M; Peloso GM; Hornsby W; Natarajan P
    medRxiv; 2023 Jun; ():. PubMed ID: 37425786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Schwartz GG; Steg PG; Szarek M; Bittner VA; Diaz R; Goodman SG; Kim YU; Jukema JW; Pordy R; Roe MT; White HD; Bhatt DL;
    Circulation; 2020 May; 141(20):1608-1617. PubMed ID: 32223446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease.
    Dittrich J; Beutner F; Teren A; Thiery J; Burkhardt R; Scholz M; Ceglarek U
    Atherosclerosis; 2019 Feb; 281():17-24. PubMed ID: 30594773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease.
    Sprenger L; Mader A; Larcher B; Mächler M; Vonbank A; Zanolin-Purin D; Leiherer A; Muendlein A; Drexel H; Saely CH
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34782334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of socioeconomic insecurity in peripheral and coronary artery disease patients.
    Joly M; Gillois P; Satger B; Blaise S; Pernod G
    J Med Vasc; 2022; 47(5-6):220-227. PubMed ID: 36464416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Sciacqua A; Perticone M; Violi F; Lip GYH
    Int J Cardiol; 2018 Mar; 255():69-73. PubMed ID: 29290420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of novel cytokines in inflammation: Defining peripheral artery disease among patients with coronary artery disease.
    Ozkaramanli Gur D; Guzel S; Akyuz A; Alpsoy S; Guler N
    Vasc Med; 2018 Oct; 23(5):428-436. PubMed ID: 29638194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Stoekenbroek RM; Boekholdt SM; Luben R; Hovingh GK; Zwinderman AH; Wareham NJ; Khaw KT; Peters RJ
    Eur Heart J; 2016 Mar; 37(11):880-9. PubMed ID: 26681771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of lipoprotein(a) for assessing the prevalence and severity of lower-extremity peripheral artery disease among patients with acute coronary syndrome.
    Okubo R; Nakanishi R; Oka Y; Kojima Y; Matsumoto S; Aikawa H; Noike R; Yabe T; Amano H; Toda M; Ikeda T
    Heart Vessels; 2023 Feb; 38(2):177-184. PubMed ID: 36068447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.
    Jadhav UM; Kadam NN
    J Assoc Physicians India; 2004 May; 52():370-5. PubMed ID: 15656025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of the serum metabolite profile with a healthy Nordic diet and risk of coronary artery disease.
    Noerman S; Kokla M; Koistinen VM; Lehtonen M; Tuomainen TP; Brunius C; Virtanen JK; Hanhineva K
    Clin Nutr; 2021 May; 40(5):3250-3262. PubMed ID: 33190988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
    Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
    Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.